The DOI matches its Crossref record; 101 of the 103 references it cites were found in a registry or an index.
Impact of advanced glycation end products (AGEs) signaling in coronary artery disease
Open accessAbstract
Coronary artery disease remains the leading cause of mortality in adult diabetic population with however, a high predominance also in non-diabetic subjects. In search of common molecular mechanisms and metabolic by-products with potential pathogenic role, increased advanced glycation end products (AGEs) present a critical biomarker for CAD development in both cases. Interaction of AGEs with their transmembrane cell receptor, RAGE in endothelial and smooth muscle cells as well as in platelets, activates intracellular signaling that leads to endothelial injury, modulation of vascular smooth muscle cell function and altered platelet activity. Furthermore, tissue accumulation of AGEs affects current treatment approaches being involved in stent restenosis. The present review provides an update of AGE-induced molecular mechanisms involved in CAD pathophysiology while it discusses emerging therapeutic interventions targeting AGE reduction and AGE-RAGE signaling with beneficial clinical outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“AGEs can stimulate cardiovascular complications in the presence or absence of hyperglycemia58.”
From Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury (2021) · cites this paper as [58]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Anti-Inflammatory Effects of Statins: Clinical Evidence and Basic Mechanisms
Jain, M. K., & Ridker, P. M. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1901 · Cited by 930
Levine, G. N., Bates, E., Blankenship, J. C., Bailey, S. R., Bittl, J. A., Cercek, B., Chambers, C. E., Ellis, S. G., Guyton, R. A., Hollenberg, S. M., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000336 · Cited by 619
Maugeri, N., Campana, L., Gavina, M., Covino, C., Metrio, M. D., Panciroli, C., Maiuri, L., Maseri, A., D’Angelo, A., Bianchi, M. E., et al. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12710 · Cited by 542
Cellular signalling of the receptor for advanced glycation end products (RAGE)
Xie, J., Méndez, J. D., Méndez-Valenzuela, V., & Aguilar-Hernández, M. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.06.013 · Cited by 525
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
(2011) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmsott · Cited by 472
Dicarbonyl Intermediates in the Maillard Reaction
THORNALLEY, P. J. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1333.014 · Cited by 459
Cassese, S., Byrne, R. A., Tada, T., Pinieck, S., Joner, M., Ibrahim, T., King, L. A., Fusaro, M., Laugwitz, K., & Kastrati, A. (2013) · Heart · doi:10.1136/heartjnl-2013-304933 · Cited by 440
Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat
Degenhardt, T. P., Alderson, N. L., Arrington, D. D., Beattie, R. J., Basgen, J. M., Steffes, M. W., Thorpe, S. R., & Baynes, J. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00207.x · Cited by 378
Fishman, S. L., Sonmez, H., Basman, C., Singh, V., & Poretsky, L. (2018) · Molecular Medicine · doi:10.1186/s10020-018-0060-3 · Cited by 330
Pleiotropic Effects of Statins: Lipid Reduction and Beyond
McFarlane, S. I., Muniyappa, R., Francisco, R., & Sowers, J. R. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.4.8412 · Cited by 317
Research works printed but not linked: 1
- Petrie, 2017, Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial, The Lancet. Diabetes and, Endocrinology, 5, 597
Cited by
Sorted by citations
Items 101–138 of 138
Taheri, F., Vasheghani‐Farahani, A., Honarkar-Shafie, E., Poorhosseini, H., Yaseri, M., & Hosseinzadeh‐Attar, M. J. (2023) · Journal of Research in Medical Sciences · doi:10.4103/jrms.jrms_293_23 · Cited by 1
Othman, H. K., Mahmud, A. M. R., & Maulood, I. M. (2024) · Iraqi Journal of Science · doi:10.24996/ijs.2024.65.2.6 · Cited by 1
Mbatha, N. A., Mushebenge, A. G.-A., & Khathi, A. (2024) · Physiologia · doi:10.3390/physiologia4020009
Mangontan, T., Berhimpon, S. L. E., & Wowor, M. F. (2024) · Medical Scope Journal · doi:10.35790/msj.v6i2.53651 · Cited by 1
Dietary Advanced Glycation End-Products (AGES) Induced Complications in Type 1 Diabetes Mellitus
Bhattacharyya, S., & Acharya, S. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1007016 · Cited by 1
Relationship Between Advanced Glycation End-Products and Cardiovascular Disease
Karimi, J. (2018) · Avicenna Journal of Medical Biochemistry · doi:10.15171/ajmb.2018.01
Advanced Glycation Endproducts (AGEs) in Food: Health Implications and Mitigation Strategies
Birch, C., & Bonwick, G. (2019) · Royal Society of Chemistry eBooks · doi:10.1039/9781788016438-00191
Shen, Y.-H., Wang, S., Wu, N., Dai, Y.-C., Zhou, Q., & Shen, J. (2020) · Research Square · doi:10.21203/rs.3.rs-85979/v1
Eleazu, C. O., Nna, V. U., Suleiman, J. B., & Mohamed, M. (2021) · Advances in biochemistry in health and disease · doi:10.1007/978-3-030-84763-0_9
Clinical Usefulness of Glycated Hemoglobin as a Biomarker of Atherogenic DyslipidemiaPreprint
Yao, C., Yen, T.-Y., & Su, T. (2022) · Research Square · doi:10.21203/rs.3.rs-1786430/v1
Ashiq, S., Ashiq, K., & Sabar, M. F. (2023) · Pakistan Heart Journal · doi:10.47144/phj.v56i1.2362
Advanced glycated end-products, renin-angiotensin system and SARSCoV2 severity
Cherneva, R. V., Youroukova, V., Valev, D., KARAFAIZ, F., & Cherneva, Z. V. (2023) · Gazzetta Medica Italiana Archivio per le Scienze Mediche · doi:10.23736/s0393-3660.22.04960-9
Liao, Y., Ke, B., Long, X., Xu, J., & Wu, Y. (2023) · Research Square · doi:10.21203/rs.3.rs-3151670/v1
Liao, Y., Ke, B., Long, X., Xu, J., & Wu, Y. (2023) · Figshare · doi:10.6084/m9.figshare.24647104
GELİŞMİŞ GLİKASYON SON ÜRÜNLERİ VE SAĞLIK ÜZERİNE ETKİSİ
Korkmaz, Y., & Gücükoğlu, A. (2024) · Samsun Sağlık Bilimleri Dergisi · doi:10.47115/jshs.1326266
The Role of Advanced Glycation End Products in Saphenous Vein Graft Failure
Akgümüş, A., Boyraz, B., & Balun, A. (2024) · Medical Principles and Practice · doi:10.1159/000541879
Untargeted Metabolite Profiling Reveals Acute Toxicity of Pentosidine on Adipose Tissue of Rats
Hu, C., Shao, Z., Wu, W., & Wang, J. (2024) · Metabolites · doi:10.3390/metabo14100539
Advanced glycation end products and human diseases
Zahra, H. A. (2025) · Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale · doi:10.4081/jbr.2025.12656
Dietary Advanced Glycation End Products (D-AGEs): Formation, Detection, and Health Implications
Seda, U. F. U. K., Zor, M., Şengül, M., & Karakütük, İ. A. (2025) · Black Sea Journal of Engineering and Science · doi:10.34248/bsengineering.1701252
Impact of myocardial revascularization surgery on the plasma metabolome
Barbosa, F. F. P., Pinto, M., Silva, A., Messias, L. O., Bertolucci, V., Scariot, P. P. M., de Carvalho, L. M., Junior, J. G. C., Porcari, A. M., & Messias, L. H. D. (2025) · Metabolomics · doi:10.1007/s11306-025-02316-1
Valk, T., & McMorrow, C. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1624682
Boca, A., Bondor, C. I., Cîmpean, S. I., Bâldea, I., Candrea, S., & Ilea, A. (2025) · Romanian Journal of Oral Rehabilitation · doi:10.62610/rjor.2025.2.17.15
Agrawal, D. S., Motta, J. C., & Ali, J. M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14176176
Liao, Y., Ke, B., Long, X., Xu, J., & Wu, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26645995
Liao, Y., Ke, B., Long, X., Xu, J., & Wu, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26645992
Liao, Y., Ke, B., Long, X., Xu, J., & Wu, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26645989
Liao, Y., Ke, B., Long, X., Xu, J., & Wu, Y. (2024) · Figshare · doi:10.6084/m9.figshare.24647359
Ousta, G. S., Adamopoulos, C., & Piperi, C. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00854
Self-citationTian, X., Chen, B., Chen, L., Liu, K., Chu, J., Liu, F., Feng, S., & Lai, L. (2026) · Food Science & Nutrition · doi:10.1002/fsn3.71708
Wang, L., Bai, T., Yan, J.-Z., Guan, P.-Y., Wen, L., Guo, H., & Zhang, T. (2026) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.70213
Biomarkers to predict outcomes in diabetic foot ulcers
Okiro, J., Fortune, K., Daly, E., McCann, L., Soltan, M., Sreenan, S., & Quondamatteo, F. (2026) · Open Research (University of Surrey) · doi:10.1002/viw.20260011 · Cited by 2
D-Ribose Glycation of Human High-Density Lipoprotein: Structural and Functional Alterations
Morresi, C., Tomaso, V. D., Ricci, G., Ferretti, G., & Bacchetti, T. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104370
Lin, X., Lv, D., Meng, W., Wang, P., & Zhang, X. (2026) · Annals of Medicine · doi:10.1080/07853890.2026.2671517
Saygılı, S. A., & Ayaz, A. (2026) · Molecules · doi:10.3390/molecules31162928
Wang, S., Zhang, Y., Zhang, M., Wang, M., Yang, T., & Xie, J. (2026) · Food Chemistry · doi:10.1016/j.foodchem.2026.150919
Wen, S., Huang, Z., Meng, L., Wan, Q., Huang, X., Huang, Y., Zhang, B., & Wang, J. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1945216
Advanced glycation, endothelial dysfunction, and the LDL paradox: Is it truly the ‘bad’ lipid?
Khan, S., Ranjan, S., Mukherjee, T., Mohanty, S., & Pattnaik, A. K. (2026) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2026.102680
Metadata
- Authors
- Kosmopoulos, M., Drekolias, D., Zavras, P. D., Piperi, C., & Papavassiliou, A. G.
- Affiliations
- National and Kapodistrian University of Athens (GR)
- Corresponding author
- Piperi, Christina
- Papavassiliou, Athanasios G.
- ORCID
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Publisher
- Elsevier BV
- Published
- 2019-03
- Volume
- 1865
- Issue
- 3
- Pages
- 611-619
- ISSN
- 0925-4439 (ISSN-L)
- OpenAlex
- W2907553212
- Cited by
- 136
- References
- 103
- Citations by year
- 2026: 15 · 2025: 22 · 2024: 20 · 2023: 27 · 2022: 21 · 2021: 14 · 2020: 11 · 2019: 5
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Keywords
- advanced glycation end products, RAGE, receptor for advanced glycation end products, coronary artery disease, AGE-RAGE signaling pathway, endothelial injury, vascular smooth muscle cells, platelet activation, in-stent restenosis, diabetic cardiovascular disease, biomarkers
- MeSH terms
- Receptor for Advanced Glycation End Products, Animals, Coronary Artery Disease, Humans, Signal Transduction, Glycation End Products, Advanced, Oxidative Stress, Myocytes, Smooth Muscle, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
